Patent application number | Description | Published |
20090090191 | Methods and structures for monitoring offshore platform supports - A method for monitoring a leg of an oilfield platform, the platform having a plurality of legs, each leg with a plurality of chords, each chord with a corresponding rack, the platform including a rack-and-pinion leg jacking system with a motor and gear system with pinions for jacking the legs up. The method, in certain aspects, including providing a load monitor with a strain sensing apparatus on a selected pinion of each rack-and-pinion system, providing a rack path differential monitoring system for monitoring rotation of the selected pinions to provide an indication of a linear displacement of the selected pinions for comparison to indicate rack path differential for racks of the legs of the platform. This abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure and is submitted with the understanding that it will not be used to interpret or limit the scope of the invention, 37 CFR 1.72(b). | 04-09-2009 |
20130189038 | Jack-Up Rig with Leg-Supported Ballast Loads - A jack-up rig for offshore operations comprises a hull. In addition, the rig comprises a support leg moveably coupled to the hull. The support leg has a central axis, an upper end, and a lower end opposite the upper end. Further, the support leg is adapted to be axially raised and lowered relative to the hull. The rig also comprises a ballast tank movably coupled to the support leg. The ballast tank is adapted to be axially raised and lowered relative to the support leg and the hull. | 07-25-2013 |
Patent application number | Description | Published |
20090275780 | PROCESS FOR CONTROLLING THE PARTICLE SIZE OF A 3-(TRIFLUOROMETHYL)PHENYL]-1-AMINOPROPANE DERIVATIVE - The invention relates to a process for tightly controlling the particle size of cinacalcet hydrochloride, i.e. a process for preparing large or small crystals of cinacalcet hydrochloride, which yields cinacalcet hydrochloride in a narrow, reproducible and consistent distribution of particles, which hence does not require to reprocess, rework or destroy material of undesired size, which is efficient and cost-effective, and which is suitable for industrial implementation. | 11-05-2009 |
20090318525 | Process For Preparing A 3-Pyrrole Substituted 2-Indolinone Malate Salt - The invention relates to the malic acid salt of N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide, to the use thereof as an intermediate for preparing the malic acid salt of sunitinib, and to pharmaceutical compositions comprising said malic acid salt of sunitinib. | 12-24-2009 |
20100267988 | PROCESSES FOR PREPARING INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF CINACALCET - The invention relates, in general, to an improved process for preparing compounds (e.g., 3-(3-trifluoromethylphenyl)propanal (Compound III, below)), which are key intermediates for the synthesis of cinacalcet, its salts and/or solvates thereof, as well as the use of such compounds prepared by such process for the preparation of cinacalcet and/or its salts or solvates. | 10-21-2010 |
20100286410 | Polymorphic Forms Of A 3-Pyrrole Substituted 2-Indolinone - The invention relates to new crystalline polymorphic forms of N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (i.e., sunitinib base), including Form I, Form II, and Form IV, processes for preparing crystalline polymorphic forms of sunitinib base, and pharmaceutically acceptable salts of new crystalline polymorphic forms of sunitinib base and pharmaceutical compositions comprising new crystalline polymorphic forms of sunitinib base, salts of new crystalline polymorphic forms of sunitinib base and mixtures thereof. | 11-11-2010 |
20100305359 | Processes For Preparing A Substituted Gamma-Amino Acid - The present invention is related to processes suitable for industrial synthesis of pregabalin from (R)-(−)-3-(carbamoylmethyl)-5-methylhexanoic using sodium hypochlorite as described herein. In addition, the present invention is related to pregabalin which is substantially free of impurities and pharmaceutical compositions comprising pregabalin. | 12-02-2010 |
20110189241 | Process For Controlling The Particle Size of A [3-(Trifluoromethyl)Phenyl]-1-Aminopropane Derivative - The invention relates to a process for tightly controlling the particle size of cinacalcet hydrochloride, i.e. a process for preparing large or small crystals of cinacalcet hydrochloride, which yields cinacalcet hydrochloride in a narrow, reproducible and consistent distribution of particles, which hence does not require to reprocess, rework or destroy material of undesired size, which is efficient and cost-effective, and which is suitable for industrial implementation. | 08-04-2011 |
20110295037 | PROCESSES FOR PREPARING CINACALCET HYDROCHLORIDE AND POLYMORPHIC FORMS THEREOF - The invention relates to cinacalcet hydrochloride, new polymorphic crystalline forms of cinacalcet hydrochloride, amorphous cinacalcet hydrochloride and synthetic processes for their preparation. | 12-01-2011 |
Patent application number | Description | Published |
20090177180 | USER INTERFACE IMPROVEMENTS FOR MEDICAL DEVICES - A method and system is disclosed for operating a medical device with or without a cassette in place. A method is disclosed for adding additional VTBI to an ongoing infusion without stopping the infusion and with maintaining the infusion parameters. A method and system is disclosed for changing the CCA without having to interrupt or completely stop an ongoing infusion. Quick titration buttons are provided to allow improved navigation between various delivery display screens. | 07-09-2009 |
20090177992 | USER INTERFACE IMPROVEMENTS FOR MEDICAL DEVICES - A method and system is disclosed for operating a medical device with or without a cassette in place. A method is disclosed for adding additional VTBI to an ongoing infusion without stopping the infusion and with maintaining the infusion parameters. A method and system is disclosed for changing the CCA without having to interrupt or completely stop an ongoing infusion. Quick titration buttons are provided to allow improved navigation between various delivery display screens. | 07-09-2009 |
20090183105 | USER INTERFACE IMPROVEMENTS FOR MEDICAL DEVICES - A method and system is disclosed for operating a medical device with or without a cassette in place. A method is disclosed for adding additional VTBI to an ongoing infusion without stopping the infusion and with maintaining the infusion parameters. A method and system is disclosed for changing the CCA without having to interrupt or completely stop an ongoing infusion. Quick titration buttons are provided to allow improved navigation between various delivery display screens. | 07-16-2009 |
20100010647 | USER INTERFACE IMPROVEMENTS FOR MEDICAL DEVICES - A method and system is disclosed for operating a medical device with or without a cassette in place. A method is disclosed for adding additional VTBI to an ongoing infusion without stopping the infusion and with maintaining the infusion parameters. A method and system is disclosed for changing the CCA without having to interrupt or completely stop an ongoing infusion. Quick titration buttons are provided to allow improved navigation between various delivery display screens. | 01-14-2010 |
20100130933 | MEDICATION MANAGMENT SYSTEM - A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads medication delivery code based on a medication delivery order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information electronically only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, sequence and dynamically adjust) medication order performance. | 05-27-2010 |
20120130308 | USER INTERFACE IMPROVEMENTS FOR MEDICAL DEVICES - A method and apparatus is disclosed for operating a medical device with a screen having an improved graphical user interface, which selectively reallocates screen display for both single and multi-channel pumps. Channel indicators associate operation information with a specific delivery channel. Patient or drug order verification is facilitated with a rendering of the patient or the entire drug order/label on the screen. Decimal numbers are presented in vertically offset decimal format. A dual function button cancels the current operation and, after a delay, clears entered parameters. An area sensitive scrollbar cycles through information at various speeds. Screen brightness is adjusted based on an ambient light detector. A screen saver mode activates based on several operating conditions. The screen is incorporated in a removable user interface. | 05-24-2012 |